featured-Reporter

Vanderbilt is the first hospital in Tennessee to use a new subcutaneous implantable defibrillator (S-ICD) to treat patients at risk for sudden cardiac arrest.

Researchers at the Scripps Research Institute in San Diego and Vanderbilt University have discovered a “missing link” in the structure of a transmembrane receptor that could lead to new treatments for autism, schizophrenia, Parkinson’s disease and Alzheimer’s disease.

Vanderbilt University scientists have found evidence that the insulin-secreting beta cells of the pancreas, which are either killed or become dysfunctional in the two main forms of diabetes, have the capacity to regenerate.

A new advanced stroke treatment suite debuts this month at Vanderbilt University Medical Center, offering better care for patients with blood circulation problems in the head and neck, such as stroke and aneurysm.

Vanderbilt Behavioral Health (VBH) opened a neuromodulation suite this week for two brain stimulation procedures that can offer relief to patients diagnosed with disabling psychiatric conditions when psychotherapy and medications don’t work or aren’t advised.

The Shade Tree Trot has come a long way since it sauntered onto Nashville’s 5K scene in 2004.

“There has never been a time when we need leaders more than today.” With these words, Jeff Balser, M.D., Ph.D., vice chancellor for Health Affairs and dean of the School of Medicine, began his quarterly conversation with colleagues at Wednesday’s Clinical Enterprise Leadership Assembly in Langford Auditorium.